| Enliven Therapeutics to Present at the Jefferies London Healthcare Conference | 11/07 16:05 | prnewswire.com |
| Why Enliven is this analyst's top biotech stock pick | 10/18 19:18 | youtube.com |
| Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why | 10/14 09:50 | zacks.com |
| Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia | 09/28 09:35 | globenewswire.com |
| Here's Why Momentum in Enliven Therapeutics, Inc. (ELVN) Should Keep going | 09/26 09:51 | zacks.com |
| Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML | 09/18 16:05 | globenewswire.com |
| Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High? | 09/04 10:56 | zacks.com |
| Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet | 08/16 10:55 | zacks.com |
| Enliven Therapeutics to Present at Two Upcoming Investor Conferences | 05/29 16:05 | globenewswire.com |
| Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update | 05/14 16:05 | globenewswire.com |